First Time Loading...

Vivos Therapeutics Inc
NASDAQ:VVOS

Watchlist Manager
Vivos Therapeutics Inc Logo
Vivos Therapeutics Inc
NASDAQ:VVOS
Watchlist
Price: 2.49 USD 23.88% Market Closed
Updated: May 15, 2024

Vivos Therapeutics Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vivos Therapeutics Inc
Operating Expenses Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Vivos Therapeutics Inc
NASDAQ:VVOS
Operating Expenses
-$25.6m
CAGR 3-Years
-4%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Operating Expenses
-$2.3B
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-3%
Quest Diagnostics Inc
NYSE:DGX
Operating Expenses
-$1.8B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
0%
CVS Health Corp
NYSE:CVS
Operating Expenses
-$40.1B
CAGR 3-Years
24%
CAGR 5-Years
3%
CAGR 10-Years
-10%
Cigna Corp
NYSE:CI
Operating Expenses
-$16.2B
CAGR 3-Years
53%
CAGR 5-Years
25%
CAGR 10-Years
6%
Laboratory Corporation of America Holdings
NYSE:LH
Operating Expenses
-$2.3B
CAGR 3-Years
-4%
CAGR 5-Years
-5%
CAGR 10-Years
-7%

See Also

What is Vivos Therapeutics Inc's Operating Expenses?
Operating Expenses
-25.6m USD

Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Operating Expenses amounts to -25.6m USD.

What is Vivos Therapeutics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-18%

Over the last year, the Operating Expenses growth was 27%. The average annual Operating Expenses growth rates for Vivos Therapeutics Inc have been -4% over the past three years , -18% over the past five years .